Back

Finasteride effectively attenuates the impairments of left ventricular function and cardiac sympathovagal balance in both aging and obese male rats via reducing systemic oxidative stress

25 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Improving outcomes in heart failure: bench to bedside Biotherapies ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Miss Nattayaporn Apaijai

Chiang Mai University, Chiang Mai (Thailand)

8 More presentations in this session

Presentation thumbnail
Are heart failure patients with mildly reduced ejection fraction treated according to current international guidelines?
Doctor T. Schupp (Mannheim, DE)
Abstract Slides Video
Presentation thumbnail
The power of optimal medical therapy in heart failure with secondary mitral regurgitation
Unknown A. Borrellas Martin (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Prescribing trends of sodium-glucose cotransporter 2 Inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction
Doctor F. Hofer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Successful treatment of pulmonary hypertension and right heart failure by antibody-based functional blocking of the extra-domain A of fibronectin in a preclinical animal model
Professor M. Franz (Rotenburg an der Fulda, DE)
Abstract Slides Video
Presentation thumbnail
Effects of colchicine treatment after myocardial infarction on top of standard therapy: evidence from a preclinical study
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Improving outcomes in heart failure: bench to bedside

The Event

Event poster

ESC Congress 2023

25 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Spermidine attenuates left ventricular dysfunction in estrogen deprived aging rats through mitigating lipid peroxidation and mitochondrial dysfunction
2 September 2024
thumbnail
Congress Presentation
Obesity plays a key role in inducing myocardial and vascular dysfunction in a translational model of heart failure with preserved ejection fraction in rats
31 August 2024
thumbnail
Congress Presentation
Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner.
28 August 2023
thumbnail
Congress Presentation
Senolysis ameliorates increased susceptibility to ventricular arrhythmias in prediabetes
7 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources